Sleep in parkinson’s disease

Sleep Disorders and Neurologic Diseases, Second Edition

Volumn , Issue , 2007, Pages 205-228

  Rodnitzky, Robert L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927019635     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9781420014693-17     Document Type: Chapter

References (156)

1. Parkinson J. An Essay on the Shaking Palsy. London: Sherwood, Neely, and Jones, 1817.
2. Askenasy JJ. Sleep patterns in extrapyramidal disorders. Int J Neurol 1981; 15:62-76.
3. Nausieda PA, Weiner WJ, Kaplan LR, et al. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol 1982; 5:183-194.
4. Lees AJ, Blackburn NA, Campbell VL. The nighttime problems of Parkinson’s disease. Clin Neuropharmacol 1988; 11:512-519.
5. van Hilten B, Hoff JI, Middelkoop HA, et al. Sleep disruption in Parkinson’s disease. Assessment by continuous activity monitoring. Arch Neurol 1994; 51:922-928.
6. Smith MC, Ellgring H, Oertel WH. Sleep disturbances in Parkinson’s disease patients and spouses. J Am Geriatr Soc 1997; 45:194-199.
7. Oerlemans WG, de Weerd AW. The prevalence of sleep disorders in patients with Parkinson’s disease. A self-reported, community-based survey. Sleep Med 2002; 3:147-149.
8. Carter J, Carroll S, Lannon MC, et al. Sleep disruption in untreated Parkinson’s disease. Neurology 1990; 40:220.
9. Diederich NJ, Vaillant M, Mancuso G, et al. Progressive sleep ‘destructuring’ in Parkinson’s disease. A polysomnographic study in 46 patients. Sleep Med 2005; 6:313-318.
10. Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2002; 73:629-635.
11. Tse W, Liu Y, Barthlen GM, et al. Clinical usefulness of the Parkinson’s disease sleep scale. Parkinsonism Relat Disord 2005; 11:317-321.
12. Friedman A. Sleep pattern in Parkinson’s disease. Acta Med Pol 1980; 21:193-199.
13. Emser W, Brenner M, Stober T, et al. Changes in nocturnal sleep in Huntington’s and Parkinson’s disease. J Neurol 1988; 235:177-179.
14. Laihinen A, Alihanka J, Raitasuo S, et al. Sleep movements and associated autonomic nervous activities in patients with Parkinson’s disease. Acta Neurol Scand 1987; 76:64-68.
15. Fish DR, Sawyers D, Allen PJ, et al. The effect of sleep on the dyskinetic movements of Parkinson’s disease, Gilles de la Tourette syndrome, Huntington’s disease, and torsion dystonia. Arch Neurol 1991; 48:210-214.
16. Tassinari CA, Broughton R, Poire R. An electro-clinical study of nocturnal sleep in patients presenting abnormal movements. Electroencephalogr Clin Neurophysiol 1965; 18:95.
17. April RS. Observations on parkinsonian tremor in all-night sleep. Neurology 1966; 16:720-724.
18. Stern M, Roffwarg H, Duvoisin R. The parkinsonian tremor in sleep. J Nerv Ment Dis 1968; 147:202-210.
19. Askenasy JJ, Yahr MD. Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep. J Neurol Neurosurg Psychiatry 1990; 53:749-753.
20. Askenasy JJ, Yahr MD. Suppression of REM rebound by Pergolide. J Neural Transm 1984; 59:151-159.
21. Lees AJ. A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson’s disease. Eur Neurol 1987; 27 Suppl 1:126-134.
22. Pahwa R, Busenbark K, Huber SJ, et al. Clinical experience with controlled-release carbidopa/levodopa in Parkinson’s disease. Neurology 1993; 43:677-681.
23. Rodnitzky RL, Dickins QS, Dobson J. Long-term clinical efficacy of Sinemet CR in patients with Parkinson’s disease. Neurology 1989; 39:92-95; discussion 95.
24. Jansen EN, Meerwaldtt JD. Madopar HBS in nocturnal symptoms of Parkinson’s disease. Adv Neurol 1990; 53:527-531.
25. Leeman AL, O’Neill CJ, Nicholson PW, et al. Parkinson’s disease in the elderly:response to and optimal spacing of night time dosing with levodopa. Br J Clin Pharmacol 1987; 24:637-643.
26. Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson’s disease patients with treatment-induced hallucinations. Ann Neurol 1993; 34:710-714.
27. Dooneief G, Mirabello E, Bell K, et al. An estimate of the incidence of depression in idiopathic Parkinson’s disease. Arch Neurol 1992; 49:305-307.
28. Starkstein SE, Preziosi TJ, Robinson RG. Sleep disorders, pain, and depression in Parkinson’s disease. Eur Neurol 1991; 31:352-355.
29. Menza MA, Rosen RC. Sleep in Parkinson’s disease. The role of depression and anxiety. Psychosomatics 1995; 36:262-266.
30. Kostic VS, Susic V, Przedborski S, et al. Sleep EEG in depressed and nondepressed patients with Parkinson’s disease. J Neuropsychiatry Clin Neurosci 1991; 3:176-179.
31. Happe S, Ludemann P, Berger K. The association between disease severity and sleeprelated problems in patients with Parkinson’s disease. Neuropsychobiology 2002; 46:90-96.
32. Koller WC, Silver DE, Lieberman A. An algorithm for the management of Parkinson’s disease. Neurology 1994; 44:S1-52.
33. Steur EN. Increase of Parkinson disability after fluoxetine medication. Neurology 1993; 43:211-213.
34. Suchowersky O, deVries JD. Interaction of fluoxetine and selegiline. Can J Psychiatry 1990; 35:571-572.
35. Richard IH, Kurlan R. A survey of antidepressant drug use in Parkinson’s disease. Parkinson Study Group. Neurology 1997; 49:1168-1170.
36. Struck LK, Rodnitzky RL, Dobson JK. Circadian fluctuations of contrast sensitivity in Parkinson’s disease. Neurology 1990; 40:467-470.
37. Rodnitzky RL, Dobson J. Circadian variability of olfactory function in Parkinson’s diseas. In: Proceedings of the 10th International Symposium on Parkinson’s Disease; 1991; Tokyo, 1991.
38. Factor SA, McAlarney T, Sanchez-Ramos JR, et al. Sleep disorders and sleep effect in Parkinson’s disease. Mov Disord 1990; 5:280-285.
39. Mayer G, Ewert Meier K, Hephata K. Selegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study. Clin Neuropharmacol 1995; 18:306-319.
40. Reinish LW, MacFarlane JG, Sandor P, et al. REM changes in narcolepsy with selegiline. Sleep 1995; 18:362-367.
41. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group. Ann Neurol 1998; 43:88-97.
42. Hogl B, Saletu M, Brandauer E, et al. Modafinil for the treatment of daytime sleepiness in Parkinson’s disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 2002; 25:905-909.
43. Adler CH, Caviness JN, Hentz JG, et al. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson’s disease. Mov Disord 2003; 18:287-293.
44. Lack L, Wright H. The effect of evening bright light in delaying the circadian rhythms and lengthening the sleep of early morning awakening insomniacs. Sleep 1993; 16:436-443.
45. Campbell SS, Murphy PJ. Extraocular circadian phototransduction in humans. Science 1998; 279:396-399.
46. Ferini-Strambi L, Franceschi M, Pinto P, et al. Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology 1992; 38:92-98.
47. Hardie RJ, Efthimiou J, Stern GM. Respiration and sleep in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1986; 49:1326.
48. Apps MC, Sheaff PC, Ingram DA, et al. Respiration and sleep in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1985; 48:1240-1245.
49. Diederich NJ, Vaillant M, Leischen M, et al. Sleep apnea syndrome in Parkinson’s disease. A case-control study in 49 patients. Mov Disord 2005; 20:1413-1418.
50. Gillin JC, Post RM, Wyatt RJ, et al. REM inhibitory effect of L-DOPA infusion during human sleep. Electroencephalogr Clin Neurophysiol 1973; 35:181-186.
51. van Hilten JJ, Weggeman M, van der Velde EA, et al. Sleep, excessive daytime sleepiness and fatigue in Parkinson’s disease. J Neural Transm Park Dis Dement Sect 1993; 5:235-244.
52. Frucht S, Rogers JD, Greene PE, et al. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999; 52:1908-1910.
53. Ferreira JJ, Galitzky M, Montastruc JL, et al. Sleep attacks and Parkinson’s disease treatment. Lancet 2000; 355:1333-1334.
54. Homann CN, Wenzel K, Suppan K, et al. Sleep attacks in patients taking dopamine agonists: review. Bmj 2002; 324:1483-1487.
55. Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson’s disease and sleepiness: an integral part of PD. Neurology 2002; 58:1019-1024.
56. Kumar S, Bhatia M, Behari M. Sleep disorders in Parkinson’s disease. Mov Disord 2002; 17:775-781.
57. Fabbrini G, Barbanti P, Aurilia C, et al. Excessive daytime sleepiness in de novo and treated Parkinson’s disease. Mov Disord 2002; 17:1026-1030.
58. Manni R, Terzaghi M, Sartori I, et al. Dopamine agonists and sleepiness in PD: review of the literature and personal findings. Sleep Med 2004; 5:189-193.
59. Pacchetti C, Martignoni E, Terzaghi M, et al. Sleep attacks in Parkinson’s disease: a clinical and polysomnographic study. Neurol Sci 2003; 24:195-196.
60. Tracik F, Ebersbach G. Sudden daytime sleep onset in Parkinson’s disease: polysomnographic recordings. Mov Disord 2001; 16:500-506.
61. Meindorfner C, Korner Y, Moller JC, et al. Driving in Parkinson’s disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 2005; 20:832-842.
62. Kales A, Ansel RD, Markham CH, et al. Sleep in patients with Parkinson’s disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 1971; 12:397-406.
63. Wyatt RJ, Chase TN, Scott J, et al. Effect of L-dopa on the sleep of man. Nature 1970; 228:999-1001.
64. Factor SA, Molho ES, Podskalny GD, et al. Parkinson’s disease: drug-induced psychiatric states. Adv Neurol 1995; 65:115-138.
65. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol 1996; 53:1265-1268.
66. Klein C, Kompf D, Pulkowski U, et al. A study of visual hallucinations in patients with Parkinson’s disease. J Neurol 1997; 244:371-377.
67. Goetz CG, Wuu J, Curgian LM, et al. Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology 2005; 64:81-86.
68. Mancini F, Tassorelli C, Martignoni E, et al. Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease. Clin Neuropharmacol 2004; 27:33-37.
69. Wolters EC, Jansen EN, Tuynman-Qua HG, et al. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson’s disease. Neurology 1996; 47:1085-1087.
70. Meco G, Alessandri A, Giustini P, et al. Risperidone in levodopa-induced psychosis in advanced Parkinson’s disease: an open-label, long-term study. Mov Disord 1997; 12:610-612.
71. Friedman JH, Lannon MC. Clozapine in the treatment of psychosis in Parkinson’s disease. Neurology 1989; 39:1219-1221.
72. Marconi R, Lefebvre-Caparros D, Bonnet AM, et al. Levodopa-induced dyskinesias in Parkinson’s disease phenomenology and pathophysiology. Mov Disord 1994; 9:2-12.
73. Pacchetti C, Albani G, Martignoni E, et al. “Off” painful dystonia in Parkinson’s disease treated with botulinum toxin. Mov Disord 1995; 10:333-336.
74. Mouret J. Differences in sleep in patients with Parkinson’s disease. Electroencephalogr Clin Neurophysiol 1975; 38:653-657.
75. Klawans HL, Goetz C, Bergen D. Levodopa-induced myoclonus. Arch Neurol 1975; 32:330-334.
76. Linazasoro G, Marti Masso JF, Suarez JA. Nocturnal akathisia in Parkinson’s disease:treatment with clozapine. Mov Disord 1993; 8:171-174.
77. Lang AE, Johnson K. Akathisia in idiopathic Parkinson’s disease. Neurology 1987; 37:477-481.
78. Thorpy MJatDCSC. The International Classificationof Sleep Disorders: Diagnostic and Coding Manual. Rochester, MN: American Sleep Disorders Association 1990.
79. Dyken ME, Rodnitzky RL. Periodic, aperiodic, and rhythmic motor disorders of sleep. Neurology 1992; 42:68-74.
80. Silber MA, Ahlskog JE. REM sleep behavior disorder in parkinsonian syndromes. Sleep Research 1992; 21:313.
81. Uchiyama M, Isse K, Tanaka K, et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology 1995; 45:709-712.
82. Louden MB, Morehead MA, Schmidt HS. Activation by selegiline (Eldepryle) of REM sleep behavior disorder in parkinsonism. W V Med J 1995; 91:101.
83. Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson’s disease with therapeutic response to levodopa. Mov Disord 1996; 11:214-216.
84. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996; 46:388-393.
85. Gagnon JF, Bedard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology 2002; 59:585-589.
86. Turner RS, Chervin RD, Frey KA, et al. Probable diffuse Lewy body disease presenting as REM sleep behavior disorder. Neurology 1997; 49:523-527.
87. Onofrj M, Thomas A, D’Andreamatteo G, et al. Incidence of RBD and hallucination in patients affected by Parkinson’s disease: 8-year follow-up. Neurol Sci 2002; 23(suppl 2):S91-94.
88. Pacchetti C, Manni R, Zangaglia R, et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson’s disease. Mov Disord 2005; 20:1439-1448.
89. Culebras A, Moore JT. Magnetic resonance findings in REM sleep behavior disorder. Neurology 1989; 39:1519-1523.
90. Askenasy JJ, Weitzman ED, Yahr MD. Are periodic movements in sleep a basal ganglia dysfunction? J Neural Transm 1987; 70:337-347.
91. Horiguchi J, Inami Y, Nishimatsu O, et al. Sleep-wake complaints in Parkinson’s disease. Rinsho Shinkeigaku 1990; 30:214-216.
92. Nomura T, Inoue Y, Miyake M, et al. Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson’s disease. Mov Disord 2006; 21:380-384.
93. Henning WA, Walters AS, Chokroverty S. Treatment of the restless legs syndrome:current practices of sleep experts. Neurology 1995; 45(suppl 4):285.
94. Vetrugno R, Contin M, Baruzzi A, et al. Polysomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome. Mov Disord 2006; 21:254-258.
95. Garcia-Borreguero D. Augmentation: understanding a key feature of RLS. Sleep Med 2004; 5:5-6.
96. Walters AS, Ondo WG, Dreykluft T, et al. Ropinirole is effective in the treatment of restless legs syndro. TREAT RLS 2: a 12-week, double-blind, randomized, parallelgroup, placebo-controlled study. Mov Disord 2004; 19:1414-1423.
97. Bonnet MH, Arand DL. Chronic use of triazolam in patients with periodic leg movements, fragmented sleep and daytime sleepiness. Aging (Milano) 1991; 3:313-324.
98. Merello M, Hughes A, Colosimo C, et al. Sleep benefit in Parkinson’s disease. Mov Disord 1997; 12:506-508.
99. Bixler EO, Kales A, Soldatos CR, et al. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 1979; 136:1257-1262.
100. Comella CL, Bohmer J, Stebbins GT. Sleep benefit in Parkinson’s disease. Neurology 1995; 45(suppl 4):286.
101. Wiley J, Lynch T, Lincoln S, et al. Parkinson’s disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutations. Mov Disord 2004; 19:677-681.
102. Currie LJ, Bennett JP Jr, Harrison MB, et al. Clinical correlates of sleep benefit in Parkinson’s disease. Neurology 1997; 48:1115-1117.
103. Wenning GK, Ben Shlomo Y, Magalhaes M, et al. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994; 117 (Pt 4):835-845.
104. Manni R, Morini R, Martignoni E, et al. Nocturnal sleep in multisystem atrophy with autonomic failure: polygraphic findings in ten patients. J Neurol 1993; 240:249-250.
105. Ghorayeb I, Yekhlef F, Chrysostome V, et al. Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002; 72:798-800.
106. Isozaki E, Naito A, Horiguchi S, et al. Early diagnosis and stage classification of vocal cord abductor paralysis in patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 1996; 60:399-402.
107. Sadaoka T, Kakitsuba N, Fujiwara Y, et al. Sleep-related breathing disorders in patients with multiple system atrophy and vocal fold palsy. Sleep 1996; 19:479-484.
108. Kakitsuba N, Sadaoka T, Kanai R, et al. Peculiar snoring in patients with multiple system atrophy: its sound source, acoustic characteristics, and diagnostic significance. Ann Otol Rhinol Laryngol 1997; 106:380-384.
109. Uzawa A, Sakakibara R, Tamura N, et al. Laryngeal abductor paralysis can be a solitary manifestation of multiple system atrophy. J Neurol Neurosurg Psychiatry 2005; 76:1739-1741.
110. Munschauer FE, Loh L, Bannister R, et al. Abnormal respiration and sudden death during sleep in multiple system atrophy with autonomic failure. Neurology 1990; 40:677-679.
111. Iranzo A, Santamaria J, Tolosa E, et al. Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology 2004; 63:930-932.
112. Ghorayeb I, Yekhlef F, Bioulac B, et al. Continuous positive airway pressure for sleeprelated breathing disorders in multiple system atrophy: long-term acceptance. Sleep Med 2005; 6:359-362.
113. Boeve BF, Silber MH, Parisi JE, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003; 61:40-45.
114. Arnulf I, Merino-Andreu M, Bloch F, et al. REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep 2005; 28:349-354.
115. Tison F, Wenning GK, Quinn NP, et al. REM sleep behaviour disorder as the presenting symptom of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995; 58:379-380.
116. Plazzi G, Corsini R, Provini F, et al. REM sleep behavior disorders in multiple system atrophy. Neurology 1997; 48:1094-1097.
117. Tachibana N, Kimura K, Kitajima K, et al. REM sleep without atonia at early stage of sporadic olivopontocerebellar atrophy. J Neurol Sci 1995; 132:28-34.
118. Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 2003; 4:281-284.
119. Golbe LI, Davis PH, Schoenberg BS, et al. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988; 38:1031-1034.
120. Aldrich MS, Foster NL, White RF, et al. Sleep abnormalities in progressive supranuclear palsy. Ann Neurol 1989; 25:577-581.
121. Montplaisir J, Petit D, Decary A, et al. Sleep and quantitative EEG in patients with progressive supranuclear palsy. Neurology 1997; 49:999-1003.
122. De Bruin VS, Machado C, Howard RS, et al. Nocturnal and respiratory disturbances in Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Postgrad Med J 1996; 72:293-296.
123. Silvestri R, De Domenico P, Di Rosa AE, et al. The effect of nocturnal physiological sleep on various movement disorders. Mov Disord 1990; 5:8-14.
124. Sforza E, Montagna P, Defazio G, et al. Sleep and cranial dystonia. Electroencephalogr Clin Neurophysiol 1991; 79:166-169.
125. Lobbezoo F, Thu Thon M, Remillard G, et al. Relationship between sleep, neck muscle activity, and pain in cervical dystonia. Can J Neurol Sci 1996; 23:285-290.
126. Fish DR, Sawyers D, Smith SJ, et al. Motor inhibition from the brainstem is normal in torsion dystonia during REM sleep. J Neurol Neurosurg Psychiatry 1991; 54:140-144.
127. Jankel WR, Allen RP, Niedermeyer E, et al. Polysomnographic findings in dystonia musculorum deformans. Sleep 1983; 6:281-285.
128. Jankel WR, Niedermeyer E, Graf M, et al. Case report: polysomnographic effects of thalamotomy for torsion dystonia. Neurosurgery 1984; 14:495-498.
129. Lugaresi E, Cirignotta F, Montagna P. Nocturnal paroxysmal dystonia. J Neurol Neurosurg Psychiatry 1986; 49:375-380.
130. Tinuper P, Cerullo A, Cirignotta F, et al. Nocturnal Paroxysmal Dystonia with shortlasting attacks: three cases with evidence for an epileptic frontal lobe origin of seizures. Epilepsia 1990; 31:549-556.
131. Hirsch E, Sellal F, Maton B, et al. Nocturnal paroxysmal dystonia: a clinical form of focal epilepsy. Neurophysiol Clin 1994; 24:207-217.
132. Oldani A, Zucconi M, Asselta R, et al. Autosomal dominant nocturnal frontal lobe epilepsy. A video-polysomnographic and genetic appraisal of 40 patients and delineation of the epileptic syndrome. Brain 1998; 121 (Pt 2):205-223.
133. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994; 8:236-242.
134. Wiegand M, Moller AA, SchreiberW, et al. Brain morphology and sleep EEG in patients with Huntington’s disease. Eur Arch Psychiatry Clin Neurosci 1991; 240:148-152.
135. Wiegand M, Moller AA, Lauer CJ, et al. Nocturnal sleep in Huntington’s disease. J Neurol 1991; 238:203-208.
136. Silvestri R, Raffaele M, De Domenico P, et al. Sleep features in Tourette’s syndrome, neuroacanthocytosis and Huntington’s chorea. Neurophysiol Clin 1995; 25:66-77.
137. Bollen EL, Den Heijer JC, Ponsioen C, et al. Respiration during sleep in Huntington’s chorea. J Neurol Sci 1988; 84:63-68.
138. Puca FM, Minervini MG, Savarese M, et al. Sleep in a case of hemiballism. Boll Soc Ital Biol Sper 1984; 60:981-987.
139. Kurlan R. Tourette’s syndrome: current concepts. Neurology 1989; 39:1625-1630.
140. Glaze DG, Frost JD Jr, Jankovic J. Sleep in Gilles de la Tourette’s syndrome: disorder of arousal. Neurology 1983; 33:586-592.
141. Cohrs S, Rasch T, Altmeyer S, et al. Decreased sleep quality and increased sleep related movements in patients with Tourette’s syndrome. J Neurol Neurosurg Psychiatry 2001; 70:192-197.
142. Burd L, Kerbeshian J. Nocturnal coprolalia and phonic tics. Am J Psychiatry 1988;145:132.
143. Comings DE, Comings BG. A controlled study of Tourette syndrome. VI. Early development, sleep problems, allergies, and handedness. Am J Hum Genet 1987; 41:822-838.
144. Barabas G, Matthews WS, Ferrari M. Somnambulism in children with Tourette syndrome. Dev Med Child Neurol 1984; 26:457-460.
145. Voderholzer U, Muller N, Haag C, et al. Periodic limb movements during sleep are a frequent finding in patients with Gilles de la Tourette’s syndrome. J Neurol 1997; 244:521-526.
146. Kostanecka-Endress T, Banaschewski T, Kinkelbur J, et al. Disturbed sleep in children with Tourette syndrome: a polysomnographic study. J Psychosom Res 2003; 55:23-29.
147. Allen RP, Singer HS, Brown JE, et al. Sleep disorders in Tourette syndrome: a primary or unrelated problem? Pediatr Neurol 1992; 8:275-280.
148. Jankovic J, Rohaidy H. Motor, behavioral and pharmacologic findings in Tourette’s syndrome. Can J Neurol Sci 1987; 14:541-546.
149. Sverd J, Montero G. Is Tourette syndrome a cause of sudden infant death syndrome and childhood obstructive sleep apnea? Am J Med Genet 1993; 46:494-496.
150. Calleja J, Carpizo R, Berciano J, et al. Serial waking-sleep EEGs and evolution of somatosensory potentials in Creutzfeldt-Jakob disease. Electroencephalogr Clin Neurophysiol 1985; 60:504-508.
151. Clouston PD, Lim CL, Fung V, et al. Brainstem myoclonus in a patient with non-doparesponsive parkinsonism. Mov Disord 1996; 11:404-410.
152. Deuschl G, Toro C, Valls-Sole J, et al. Symptomatic and essential palatal tremor. 1. Clinical, physiological and MRI analysis. Brain 1994; 117 (Pt 4):775-788.
153. Bauleo S, De Mitri P, Coccagna G. Evolution of segmental myoclonus during sleep:polygraphic study of two cases. Ital J Neurol Sci 1996; 17:227-232.
154. Montagna P, Provini F, Plazzi G, et al. Propriospinal myoclonus upon relaxation and drowsiness: a cause of severe insomnia. Mov Disord 1997; 12:66-72.
155. Manconi M, Sferrazza B, Iannaccone S, et al. Case of symptomatic propriospinal myoclonus evolving toward acute “myoclonic status.” Mov Disord 2005; 20:1646-1650.
156. Yokota T, Hirose K, Tanabe H, et al. Sleep-related periodic leg movements (nocturnal myoclonus) due to spinal cord lesion. J Neurol Sci 1991; 104:13-18.